-+ 0.00%
-+ 0.00%
-+ 0.00%

CSL AND ALENTIS ANNOUNCE GLOBAL PARTNERSHIP TO DEVELOP AND COMMERCIALISE LIXUDEBART FOR RARE KIDNEY AND LIVER DISEASES

Reuters·10/04/2026 21:42:31

Please log in to view news